Assessment of the Efficacy of Carnipure® AAS on Body Composition, Muscle Thickness, and Strength Adaptations in Healthy Men

Inclusion Criteria: Healthy male subjects 18-40 years old Recreationally trained (>6-months but <1-year of training experience) Not currently consuming any ergogenic supplements or performance enhancing drugs Body mass index (BMI) 18-29 kg/m2 No recent injuries that would contraindicate participation in a resistance training program Willing and able to give written informed consent Able to read, understand, sign and date the informed consent document (English only) Able and willing to comply with the schedule visit(s) and study requirements. Exclusion Criteria: Currently taking (within the past 30 days) ergogenic dietary supplements including, creatine, protein, amino acids, or stimulants other than caffeine (yohimbe, ephedrine, etc.) Currently taking performance enhancing drugs (testosterone or other anabolic-androgenic steroids), human growth hormone, insulin, etc. History or current malignancy Receiving chemotherapy agents or radiation treatments Musculoskeletal disease (muscular dystrophy, arthritis, etc.) Recent (<3-months) musculoskeletal injuries BMI <18 or >30 kg/m2 Diagnosis of a terminal illness Use of prescription medications that influence muscle anabolism (i.e., prescription hormone therapies, etc.) History of alcohol abuse History or current drug abuse History or current cigarette smoke (including vaping) within the past 14 days from the screening visit Insulin-dependent diabetes and/or metformin use Chronic kidney or liver disease Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such conditions might be aggravated as a result of treatment The investigator feels that for any reason the subject is not eligible to participate in the study History of uncontrolled cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other) Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurements A family member of the investigator or an employee of the investigator Participation in any other investigational study within 30 days prior to consent.